IQVIA™ Real-World Insights Bibliography

Real-world treatment and health care resource use among severe asthma patients in Japan
Author(s): Yasuo To 1; Yurie Taguchi 2; Tatsuya Shimazaki 2; Kazuhiko Arima 2; Eric Yu 3; Demiya Sven 3; Takashi Iwanaga 4
Affiliations(s): 1: Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan 2: Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan 3: IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan 4: Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan
Publication(s):  Respiratory Investigation
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Clinical practice,
2021
  L:
A:
English
Database Study,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study.
Author(s): Ishii H 1, Shuichi S 2, Williams P 3, Demiya S 4, Aranishi T 2, Treuer T 5.
Affiliations(s): 1 Department of Diabetology, Nara Medical University, Nara, Japan. 2 Eli Lilly Japan, K.K., Kobe, Japan. 3 RWE Patient-Centered Endpoints Center of Excellence, IQVIA, Paris, France. Electronic address: Paul.Williams@iqvia.com. 4 IQVIA Solutions K.K., Tokyo Japan. 5 Eli Lilly and Company, Budapest, Hungary.
Publication(s):  Diabetes Res Clin Pract.
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Diabetes,
2020
  L:
A:
English
Patient questionnaire,
  Add to report
 
 
Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions.
Author(s): Masaya H, Kenji H, Masafumi O, Ainiwaer D, Masaaki I, Takeshi A
Affiliations(s): IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  ISPOR Asia Pacific 2020 Conference
Document Type(s): Abstract,
Countries: Japan,
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
De-identification / anonymisation ,
  Add to report
 
 
Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan
Author(s): Iguch.T1, Nakamura.Y2, Akiyama.T3, Krishant C3, Yu E3
Affiliations(s):  1 Osaka City University Graduate School of Medicine Urology and Pathology, 2 Bayer Yakuhin Co., Ltd. Market Access Headquarters, 3 IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions
Publication(s):  Accepted Presentation Japanese Urological Association 2020
Document Type(s): Abstract,
Countries: Japan,
C:
Y:
Oncology,
2020
  L:
A:
English
Survey research,
  Add to report
 
 
A SYSTEMATIC LITERATURE REVIEW OF THE DISEASE AND ECONOMIC BURDEN OF MULTIDRUG RESISTANCE GRAM NEGATIVE INFECTIONS (MRGN) IN JAPAN.
Author(s): Hara, T1. Tawseef, A2, Mitsuo, R2
Affiliations(s): 1. SHIONOGI Personnel; 2. IQVIA Solutions Japan K.K.
Publication(s):  ISPOR 2020 Asia
Document Type(s): Abstract,
Countries: Japan,
C:
Y:
Drug Utlization Study,
2020
  L:
A:
English
Burden of illness, Review,
  Add to report
 
 
Retrospective Study for Comorbidities in ACTIVE Population Using Japanese Health Insurance Claims Database
Author(s): Seok-Won Kim, Ayumi Morishita, Takeshi Akiyama
Affiliations(s): Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publication(s):  ISPOR Asia Pacific 2020 Conference
Document Type(s): Abstract,
Countries: Japan,
C:
Y:
Database Validity and methodology,
2020
  L:
A:
English
Database Study,
  Add to report
 
 
Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Author(s): Masakazu Yamada 1 , Tadashi Nakano 2 , Hiroyuki Matsuda 3 , Seok-Won Kim 3 , Yasutaka Takagi 4
Affiliations(s): 1Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan. 2Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan. 3Real World Evidence Solutions, IQVIA solutions Japan, Tokyo, Japan. 4Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd. Osaka, Japan.
Publication(s):  Journal medical economics
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Health economics,
2020
  L:
A:
English
Budget impact, Cost effectiveness,
  Add to report
 
 
Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
Author(s): Toyomi Kamesaki 1 , Jun-Ichi Nishimura 2 , Hideho Wada 3 , Eric Yu 4 , Elisa Tsao 5 , Jaime Morales 5 , Yuzuru Kanakura 2 6
Affiliations(s): 1 Division of Support in Community Medicine, Center for Community Medicine, Regional Medical Center, Center for Regional Medical Care, Jichi Medical University, 3311 - 1 Yakushiji Shimotsuke-shi, Tochigi, Japan. kmskt@jicji.ac.jp. 2 Osaka University, Osaka, Japan. 3 Kawasaki Medical School, Kurashiki, Japan. 4 IQVIA Solutions K.K., Tokyo, Japan. 5 Sanofi, Waltham, MA, USA. 6 Sumitomo Hospital, Osaka, Japan.
Publication(s):  International journal of hematology
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Rare Diseases,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
Author(s): Akihito Uda, MPH,* Yuki Eto, MSc,* Yuxin Li, MSc,† Hiroyuki Matsuda, MSc,‡ Sven Demiya, PhD, MBA,‡ Tomoyuki Watanabe, PhD,* Mihoko Ota, MMA,* Ryuichi Iwakiri, MD, PhD,* and Ataru Igarashi, PhD,§,‖
Affiliations(s):  *Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan; †IQVIA Solutions UK Ltd., London, UK; ‡IQVIA Solutions Japan KK, Tokyo, Japan; §Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan; ‖Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
Publication(s):  Crohn's & Colitis 360
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Health economics,
2020
  L:
A:
English
Budget impact, Cost effectiveness, Economic evaluation,
  Add to report
 
 
 1 of 4 Next Page Last Page